Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214753683> ?p ?o ?g. }
- W4214753683 endingPage "490" @default.
- W4214753683 startingPage "476" @default.
- W4214753683 abstract "In France, two therapeutic strategies can be offered after fingolimod (FNG) withdrawal to highly active relapsing–remitting multiple sclerosis (RRMS) patients: natalizumab (NTZ) or anti-CD20. We compared the effectiveness of these two strategies as a switch for FNG within the OFSEP database. The primary endpoint was the time to first relapse. Other outcomes were the relapse rates over 3-month periods, time to worsening the EDSS score, proportion of patients with worsened 24-month MRI, time to treatment discontinuation, and incidence rates of serious adverse events. The dynamics of event rates over time were modeled using multidimensional penalized splines, allowing the possibility to model the effects of covariates in a flexible way, considering non-linearity and interactions. A total of 740 patients were included (337 under anti-CD20 and 403 under NTZ). There was no difference between the two treatments regarding the dynamic of the first occurrence of relapse, with a monthly probability of 5.0% at initiation and 1.0% after 6 months. The rate of EDSS worsening increased in both groups until 6 months and then decreased. No difference in the proportion of patients with new T2 lesions at 24 months was observed. After 18 months of follow-up, a greater risk of NTZ discontinuation was found compared to anti-CD20. This study showed no difference between NTZ and anti-CD20 after the FNG switch regarding the clinical and radiological activity. The effect of these treatments was optimal after 6 months and there was more frequent discontinuation of NTZ after 18 months, probably mainly related to JC virus seroconversions." @default.
- W4214753683 created "2022-03-02" @default.
- W4214753683 creator A5001830388 @default.
- W4214753683 creator A5002747209 @default.
- W4214753683 creator A5002947445 @default.
- W4214753683 creator A5004199452 @default.
- W4214753683 creator A5005352271 @default.
- W4214753683 creator A5006441107 @default.
- W4214753683 creator A5006513938 @default.
- W4214753683 creator A5006997286 @default.
- W4214753683 creator A5007098026 @default.
- W4214753683 creator A5009282279 @default.
- W4214753683 creator A5011213325 @default.
- W4214753683 creator A5019793757 @default.
- W4214753683 creator A5024592685 @default.
- W4214753683 creator A5025662371 @default.
- W4214753683 creator A5026828194 @default.
- W4214753683 creator A5027817455 @default.
- W4214753683 creator A5035397915 @default.
- W4214753683 creator A5035890515 @default.
- W4214753683 creator A5038329824 @default.
- W4214753683 creator A5038662347 @default.
- W4214753683 creator A5045540371 @default.
- W4214753683 creator A5045599207 @default.
- W4214753683 creator A5047268222 @default.
- W4214753683 creator A5051546835 @default.
- W4214753683 creator A5054006135 @default.
- W4214753683 creator A5061117122 @default.
- W4214753683 creator A5064342215 @default.
- W4214753683 creator A5064932437 @default.
- W4214753683 creator A5071608998 @default.
- W4214753683 creator A5076007777 @default.
- W4214753683 creator A5082292870 @default.
- W4214753683 creator A5083907860 @default.
- W4214753683 creator A5084261048 @default.
- W4214753683 creator A5089878407 @default.
- W4214753683 date "2022-02-25" @default.
- W4214753683 modified "2023-10-17" @default.
- W4214753683 title "Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis After Fingolimod Withdrawal" @default.
- W4214753683 cites W1803778850 @default.
- W4214753683 cites W1970547229 @default.
- W4214753683 cites W1986991730 @default.
- W4214753683 cites W2000175930 @default.
- W4214753683 cites W2064687595 @default.
- W4214753683 cites W2103758700 @default.
- W4214753683 cites W2104948944 @default.
- W4214753683 cites W2107008240 @default.
- W4214753683 cites W2122545833 @default.
- W4214753683 cites W2141111992 @default.
- W4214753683 cites W2142577589 @default.
- W4214753683 cites W2142635246 @default.
- W4214753683 cites W2151340435 @default.
- W4214753683 cites W2158338004 @default.
- W4214753683 cites W2159712156 @default.
- W4214753683 cites W2164556363 @default.
- W4214753683 cites W2169726349 @default.
- W4214753683 cites W2196420394 @default.
- W4214753683 cites W2274125150 @default.
- W4214753683 cites W2313484897 @default.
- W4214753683 cites W2561881161 @default.
- W4214753683 cites W2565433170 @default.
- W4214753683 cites W2784268727 @default.
- W4214753683 cites W2808600279 @default.
- W4214753683 cites W2904722354 @default.
- W4214753683 cites W2906720084 @default.
- W4214753683 cites W2912141387 @default.
- W4214753683 cites W2945745581 @default.
- W4214753683 cites W2963491578 @default.
- W4214753683 cites W2969766999 @default.
- W4214753683 cites W2972029908 @default.
- W4214753683 cites W3048359327 @default.
- W4214753683 cites W3162915930 @default.
- W4214753683 cites W3163399919 @default.
- W4214753683 cites W4298870098 @default.
- W4214753683 cites W4379510236 @default.
- W4214753683 doi "https://doi.org/10.1007/s13311-022-01202-1" @default.
- W4214753683 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35217934" @default.
- W4214753683 hasPublicationYear "2022" @default.
- W4214753683 type Work @default.
- W4214753683 citedByCount "4" @default.
- W4214753683 countsByYear W42147536832022 @default.
- W4214753683 countsByYear W42147536832023 @default.
- W4214753683 crossrefType "journal-article" @default.
- W4214753683 hasAuthorship W4214753683A5001830388 @default.
- W4214753683 hasAuthorship W4214753683A5002747209 @default.
- W4214753683 hasAuthorship W4214753683A5002947445 @default.
- W4214753683 hasAuthorship W4214753683A5004199452 @default.
- W4214753683 hasAuthorship W4214753683A5005352271 @default.
- W4214753683 hasAuthorship W4214753683A5006441107 @default.
- W4214753683 hasAuthorship W4214753683A5006513938 @default.
- W4214753683 hasAuthorship W4214753683A5006997286 @default.
- W4214753683 hasAuthorship W4214753683A5007098026 @default.
- W4214753683 hasAuthorship W4214753683A5009282279 @default.
- W4214753683 hasAuthorship W4214753683A5011213325 @default.
- W4214753683 hasAuthorship W4214753683A5019793757 @default.
- W4214753683 hasAuthorship W4214753683A5024592685 @default.
- W4214753683 hasAuthorship W4214753683A5025662371 @default.
- W4214753683 hasAuthorship W4214753683A5026828194 @default.